Article Versions Notes

Grosskopf A, Rahn J, Kim A, Szabó G, Rujescu D, Klawonn F, Frolov A, Simm A. Peptide-Bound Glycative, AGE and Oxidative Modifications as Biomarkers for the Diagnosis of Alzheimer’s Disease—A Feasibility Study. Biomedicines. 2024; 12(9):2127. https://doi.org/10.3390/biomedicines12092127

Grosskopf, Anne, Jette Rahn, Ahyoung Kim, Gábor Szabó, Dan Rujescu, Frank Klawonn, Andrej Frolov, and Andreas Simm. 2024. "Peptide-Bound Glycative, AGE and Oxidative Modifications as Biomarkers for the Diagnosis of Alzheimer’s Disease—A Feasibility Study" Biomedicines 12, no. 9: 2127. https://doi.org/10.3390/biomedicines12092127

Grosskopf, A., Rahn, J., Kim, A., Szabó, G., Rujescu, D., Klawonn, F., Frolov, A., & Simm, A. (2024). Peptide-Bound Glycative, AGE and Oxidative Modifications as Biomarkers for the Diagnosis of Alzheimer’s Disease—A Feasibility Study. Biomedicines, 12(9), 2127. https://doi.org/10.3390/biomedicines12092127